TACROLIMUS 0.1%

TACROLIMUS 0.1%- tacrolimus solution
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Directions for use

ws
(click image for full-size original)

Sincerus Florida, LLC. Adverse reactions

da

Active, inactive

cs
(click image for full-size original)

NDC 72934-4173-8. TACROLIMUS MONOHYDRATE USP 0.1%. Solution 60 gm.

zc
(click image for full-size original)

TACROLIMUS 0.1%
tacrolimus 0.1% solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72934-4173
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TACROLIMUS (TACROLIMUS ANHYDROUS) TACROLIMUS ANHYDROUS 0.1 g in 100 g
Product Characteristics
Color white (clear solution) Score
Shape Size
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:72934-4173-8 60 g in 1 BOTTLE, GLASS None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 05/10/2019
Labeler — Sincerus Florida, LLC (080105003)
Establishment
Name Address ID/FEI Operations
Sincerus Florida, LLC 080105003 manufacture (72934-4173)

Revised: 05/2019 Sincerus Florida, LLC

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.